FDG-PET shows promise in diagnosing mesothelioma

12/3/2012 | SurvivingMesothelioma.com

A Japanese study published in Experimental and Therapeutic Medicine found that patients with malignant mesothelioma had higher FDG-PET maximum standardized uptake value compared with patients with non-malignant pleural disease. Patients with the highest SUVmax levels also had the lowest chance of long-term survival, according to the study. "Our data suggest that SUVmax levels are useful as an aid for diagnosis and prognosis of malignant pleural mesothelioma," the researchers said.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT